Business
Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions
SHANGHAI, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, signed a strategic partnership with Innovent Biologics to integrate digital health services with innovative therapies in metabolic diseases and weight management. Fangzhou’s founder, chairman and CEO Dr. Xie Fangmin and Innovent Biologics Vice President of Retail Tan Zaiqiang attended the signing ceremony. Fangzhou signed a strategic partnershi
About this update from Innovent Biologics, Inc.
[{"type":"image","alt":"Fangzhou Inc.","displaySize":"","headline":null,"caption":"Fangzhou Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":95,"url":"https://media.zenfs.com/en/globenewswire.com/912b0b077ef808f302b710d614115ef6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3I4M1onr9I9LGQ_MtZRvAw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/912b0b077ef808f302b710d614115ef6","width":300,"height":95}},"lazy":false},{"type":"text","content":"SHANGHAI, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, signed a strategic partnership with Innovent Biologics to integrate digital health services with innovative therapies in metabolic diseases and weight management. Fangzhou’s founder, chairman and CEO Dr. Xie Fangmin and Innovent Biologics Vice President of Retail Tan Zaiqiang attended the signing ceremony.","length":486,"tagName":"p"},{"type":"image","alt":"Two men shaking hands and holding red documents.","displaySize":"","headline":null,"caption":"Two men shaking hands and holding red documents.","className":"","disableSlideshowImg":false,"size":{"original":{"width":2402,"height":1601,"url":"https://media.zenfs.com/en/globenewswire.com/f9786dc9ed621f9e59a143d7a6723ef6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WOeaIBLtpUinZ8i4ddVGDA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f9786dc9ed621f9e59a143d7a6723ef6","width":960,"height":640},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/wUF8sOBEFHfeY1SVM1ibLQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xNjAwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/f9786dc9ed621f9e59a143d7a6723ef6","width":1200,"height":800}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"Fangzhou signed a strategic partnership with Innovent Biologics","length":63,"tagName":"p"},{"type":"text","content":"The alliance will bring together Fangzhou’s AI-enabled “H2H” digital healthcare ecosystem and Innovent’s pipeline of novel therapies for diabetes and obesity, pioneering a new model that blends AI technology, innovative products and personalized services. The partnership comes as China’s weight management market accelerates,...